Phio Pharmaceuticals Corp. (PHIO)

1.09 -0.03 (-2.68%) USD  |  NASDAQ  |  Dec 15, 16:00
1.08 -0.01 (-0.92%) After-Hours: 04:20
More

Phio Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Tharimmune, Inc. --
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --
Oragenics, Inc. --